CT Versus CEUS Findings of Complex Cystic Renal Lesions

This study has been completed.
Sponsor:
Information provided by:
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT01159717
First received: July 8, 2010
Last updated: July 12, 2010
Last verified: July 2010
  Purpose

Retrospective comparison of complex cystic renal lesions which are found with computed tomography (CT) and were controlled with contrast enhanced ultrasound (CEUS).


Condition
Kidney Neoplasms
Computed Tomography
Ultrasonography
Contrast Media

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Complex Cystic Renal Lesions: Evaluation of Computed Tomography Findings With Contrast Enhanced Ultrasound in Terms of the Bosniak Classification System.

Resource links provided by NLM:


Further study details as provided by University Hospital, Basel, Switzerland:

Enrollment: 35
Study Start Date: January 2007
Study Completion Date: July 2010
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Detailed Description:

All subjects receive an contrast enhanced CT due to different clinical indications. When a complex cystic renal lesion is found an evaluation with CEUS is performed. The CEUS protocol included a native baseline examination of both kidneys. After a bolus injection of 1.5 ml SonoVue (Bracco, Milano, Italy) an examination of the affected kidneys is performed over a time period of at least three minutes. An optional dose will be given when the initial examination is not conclusive, e. g. when the arterial phase is partly missed. When both examinations are done the lesions were classified using the Bosniak classification system and a comparison of both methods will be done.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

All patients undergoing a CT procedure.

Criteria

Inclusion Criteria:

  • Finding of a complex cystic renal lesion

Exclusion Criteria:

  • age < 18 y, gravity
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01159717

Locations
Switzerland
Department of Radiology, University Hospital Basel, University of Basel
Basel, Switzerland, 4031
Sponsors and Collaborators
University Hospital, Basel, Switzerland
Investigators
Principal Investigator: Joachim Hohmann, MD Department of Radiology, University Hospital Basel, University of Basel
  More Information

No publications provided

Responsible Party: Dr. Joachim Hohmann, Department of Radiology
ClinicalTrials.gov Identifier: NCT01159717     History of Changes
Other Study ID Numbers: EK 129/09
Study First Received: July 8, 2010
Last Updated: July 12, 2010
Health Authority: Switzerland: Swissmedic

Additional relevant MeSH terms:
Neoplasms
Kidney Neoplasms
Urologic Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Kidney Diseases
Urologic Diseases

ClinicalTrials.gov processed this record on August 26, 2014